NYSE:KAPA | Income Statement | Kairos Pharma, LTD.

Complete source-backed income-statement history.

Available history
2023-09-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$619,000.00$1.42M-$1.42M$29,000.00-$1.39M-$0.06-$0.0621,420,47921,420,479
2026-03-31$684,000.00$1.69M-$1.69M$36,000.00-$1.65M-$0.08-$0.0821,010,13221,010,132
2025-12-31$538,000.00$1.42M-$1.42M$50,000.00-$1.37M-$0.07-$0.07806,623806,623
2025-09-30$608,000.00$1.44M-$1.44M$37,000.00-$1.4M-$0.07-$0.0720,206,03320,206,033
2025-06-30$496,000.00$1.46M-$1.46M$34,000.00-$1.42M-$0.08-$0.0817,213,01717,213,017
2025-03-31$493,000.00$1.27M-$1.27M$4,000.00-$1.26M-$0.08-$0.0815,875,48515,875,485
2024-12-31$172,000.00$1.45M-$1.45M$466,000.00-$980,000.00-$0.08-$0.08676,675676,675
2024-09-30$14,000.00$383,000.00-$383,000.00-$664,000.00-$1.05M-$0.10-$0.1010,910,22710,910,227
2024-06-30$63,000.00$222,000.00-$222,000.00-$31,000.00-$253,000.00-$0.02-$0.0210,562,64010,562,640
2024-03-31$165,000.00$287,000.00-$287,000.00-$36,000.00-$323,000.00-$0.03-$0.0310,562,64010,562,640
2023-12-31$7,000.00$1.09M-$1.09M-$29,000.00-$1.12M-$0.10-$0.1048,15848,158
2023-09-30$33,000.00$287,000.00-$287,000.00-$25,000.00-$312,000.00-$0.03-$0.0310,334,35710,334,357

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$2.14M$5.57M-$5.57M$125,000.00-$5.45M-$0.30-$0.3018,427,78718,427,787
2024-12-31$414,000.00$2.34M-$2.34M-$260,000.00-$2.6M-$0.23-$0.2311,356,45111,356,451
2023-12-31$82,000.00$1.71M-$1.71M-$98,000.00-$1.81M-$0.17-$0.1710,382,51510,382,515